TAOX Stock Summary and Trading Ideas (Tao Synergies | NASDAQ:TAOX)

TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.

Tao Synergies trades on the NASDAQ stock market under the symbol TAOX.

As of August 28, 2026, TAOX stock price declined to $3.89 with 181,822 million shares trading.

TAOX has a beta of 0.93, meaning it tends to be less sensitive to market movements. TAOX has a correlation of 0.02 to the broad based SPY ETF.

TAOX has a market cap of $29.11 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that TAOX belongs to (by Net Assets): VXF, VTI, IWC, DFMC.

TAOX has underperformed the market in the last year with a return of -40.6%, while the SPY ETF gained +19.7%. In the last 3 month period, TAOX fell short of the market, returning -11.2%, while SPY returned +2.2%. However, in the most recent 2 weeks TAOX has outperformed the stock market by returning +13.1%, while SPY returned -0.9%.

TAOX support price is $4.02 and resistance is $4.54 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TAOX shares will trade within this expected range on the day.